Go Pro

Avalo Therapeutics (AVTX) Institutional Ownership

Avalo Therapeutics logo
$19.62 -0.34 (-1.68%)
As of 10:42 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Avalo Therapeutics (NASDAQ:AVTX)

Current
Institutional Ownership
Percentage
87.06%
Number of
Institutional Buyers
(last 12 months)
57
Total
Institutional Inflows
(last 12 months)
$162.82M
Number of
Institutional Sellers
(last 12 months)
17
Total
Institutional Outflows
(last 12 months)
$37.70M
Get AVTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Avalo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

AVTX Institutional Buying and Selling by Quarter

Avalo Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
6/4/2026Seven Fleet Capital Management LP573,883$8.57M2.7%+806.0%1.092%
6/3/2026DV Trading LLC360,064$5.38M0.1%N/A0.685%
5/26/2026Glenmede Trust Co. NA25,730$384K0.0%+25.8%0.049%
5/19/2026Bank of America Corp DE643,000$9.60M0.0%+3.5%2.193%
5/19/2026Stempoint Capital LP134,742$2.01M0.4%-0.6%0.459%
5/18/2026Exome Asset Management LLC159,341$2.38M1.2%N/A0.543%
5/16/2026Orbimed Advisors LLC475,165$7.09M0.1%-60.0%1.620%
5/15/2026OMERS ADMINISTRATION Corp11,800$176K0.0%-39.8%0.040%
5/15/2026Affinity Asset Advisors LLC1,340,840$20.02M1.0%+27.6%4.572%
5/14/2026Renaissance Technologies LLC120,114$1.79M0.0%+556.4%0.410%
5/14/2026Sei Investments Co.56,854$849K0.0%N/A0.194%
5/7/2026Dimensional Fund Advisors LP40,821$607K0.0%N/A0.153%
5/7/2026AlphaCentric Advisors LLC11,668$174K0.2%N/A0.044%
5/6/2026Jennison Associates LLC470,775$7.03M0.0%-1.0%1.763%
2/26/2026Seven Fleet Capital Management LP63,343$1.15M0.9%N/A0.342%
2/18/2026XTX Topco Ltd40,458$735K0.0%+190.0%0.219%
2/18/2026Squadron Capital Management LLC130,000$2.36M1.0%N/A0.702%
2/18/2026SummitTX Capital L.P.195,873$3.56M0.1%N/A1.058%
2/18/2026Superstring Capital Management LP153,313$2.78M1.5%-18.5%0.828%
2/18/2026Quadrature Capital Ltd53,044$963K0.0%-3.6%0.287%
2/18/2026Orbimed Advisors LLC1,187,300$21.56M0.5%-12.0%6.414%
2/18/2026Millennium Management LLC659,979$11.99M0.0%+380.2%3.566%
2/18/2026Artia Global Partners LP41,570$755K0.1%N/A0.225%
2/18/2026Balyasny Asset Management L.P.439,312$7.98M0.0%-46.3%2.373%
2/18/2026683 Capital Management LLC56,850$1.03M0.0%N/A0.307%
2/17/2026Caligan Partners LP881,533$16.01M1.3%+5.8%4.762%
2/17/2026Jain Global LLC217,292$3.95M0.0%N/A1.174%
2/17/2026Jump Financial LLC13,092$238K0.0%N/A0.071%
2/17/2026Adage Capital Partners GP L.L.C.550,000$9.99M0.0%+112.5%2.971%
2/17/2026Atom Investors LP51,194$930K0.1%N/A0.277%
2/17/2026Fred Alger Management LLC80,092$1.45M0.0%N/A0.433%
2/17/2026ExodusPoint Capital Management LP32,267$586K0.0%N/A0.174%
2/17/2026Persistent Asset Partners Ltd15,087$274K0.1%N/A0.082%
2/16/2026Squarepoint Ops LLC40,854$742K0.0%N/A0.221%
2/16/2026OMERS ADMINISTRATION Corp19,600$356K0.0%N/A0.106%
2/16/2026Barclays PLC105,814$1.92M0.0%+1,032.2%0.572%
2/13/2026Marshall Wace LLP507,550$9.22M0.0%+806.2%2.742%
2/13/2026Walleye Capital LLC41,693$757K0.0%-6.8%0.225%
2/13/2026Affinity Asset Advisors LLC1,051,054$19.09M1.1%+4.5%5.677%
2/13/2026Hudson Bay Capital Management LP16,771$305K0.0%N/A0.091%
Buy this stock today (Ad)

Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to move out of overpriced AI stocks before the tech trade breaks down and into lesser-known names with real potential to challenge the Mag 7. One pick he calls 'an upgrade to Tesla stock' is a little-known company that just inked a partnership with Nvidia, positioning it ahead of Tesla in the autonomous vehicle race.tc pixel

Get the name, ticker, and full Hotlist before markets open
2/13/2026State Street Corp79,254$1.44M0.0%+74.4%0.428%
2/12/2026Jane Street Group LLC178,855$3.25M0.0%N/A0.966%
2/12/2026Renaissance Technologies LLC18,300$332K0.0%-81.5%0.099%
2/12/2026Patient Square Capital LP311,966$5.67M1.2%+212.0%1.685%
2/11/2026Deutsche Bank AG150,000$2.72M0.0%N/A0.810%
2/10/2026Goldman Sachs Group Inc.65,313$1.19M0.0%N/A0.353%
2/9/2026Geode Capital Management LLC166,152$3.02M0.0%+59.5%0.898%
2/4/2026Nan Fung Trinity HK Ltd.189,000$3.43M0.3%N/A1.021%
1/30/2026Jennison Associates LLC475,625$8.64M0.0%N/A2.570%
1/30/2026Moody Aldrich Partners LLC133,231$2.42M0.5%N/A0.720%
1/29/2026UBS Group AG477,816$8.68M0.0%+956.9%2.581%
1/16/2026Aberdeen Group plc95,426$1.73M0.0%+31.1%0.516%
1/16/2026PFS Partners LLC2,000$36K0.0%+100.0%0.011%
12/1/2025Cantor Fitzgerald L. P.85,247$1.08M0.0%N/A0.470%
11/17/2025Velan Capital Investment Management LP263,642$3.35M3.1%+70.1%1.454%
11/17/2025RA Capital Management L.P.662,968$8.43M0.1%-28.9%3.656%
11/17/2025Prelude Capital Management LLC24,628$313K0.0%N/A0.136%
11/17/2025Nantahala Capital Management LLC1,235,000$15.70M0.5%+24.1%6.810%
11/17/2025Millennium Management LLC137,431$1.75M0.0%N/A0.758%
11/17/2025HighVista Strategies LLC27,778$353K0.1%N/A0.153%
11/17/2025Boxer Capital Management LLC125,000$1.59M0.5%N/A0.689%
11/17/2025Cantor Fitzgerald L. P.85,247$1.08M0.0%N/A0.470%
11/17/2025Bank of America Corp DE605,842$7.70M0.0%+49.0%3.341%
11/17/2025Boothbay Fund Management LLC228,297$2.90M0.0%+1,916.6%1.259%
11/17/2025Ally Bridge Group NY LLC178,100$2.26M1.4%N/A0.982%
11/17/2025Ameriprise Financial Inc.213,572$2.71M0.0%N/A1.178%
11/14/2025Deep Track Capital LP144,600$1.84M0.1%-74.5%1.099%
11/14/2025Caligan Partners LP833,333$10.59M1.4%N/A6.336%
11/14/2025Orbimed Advisors LLC1,349,300$17.15M0.4%+39.5%10.259%
11/14/2025ADAR1 Capital Management LLC32,393$412K0.0%-69.1%0.246%
11/14/2025Balyasny Asset Management L.P.817,436$10.39M0.0%N/A6.215%
11/14/2025Two Sigma Investments LP49,242$626K0.0%+282.0%0.374%
11/13/2025Landscape Capital Management L.L.C.33,337$424K0.0%N/A0.254%
11/13/2025UBS Group AG45,208$575K0.0%-46.0%0.344%
11/12/2025Dimensional Fund Advisors LP11,215$143K0.0%N/A0.085%
11/10/2025RWA Wealth Partners LLC86,516$1.10M0.0%-66.9%0.658%
11/10/2025Patient Square Capital LP100,000$1.27M0.3%N/A0.760%
11/10/2025BIT Capital GmbH1,929$25K0.0%N/A0.015%
11/7/2025Vanguard Group Inc.692,637$8.80M0.0%+314.9%5.267%
11/7/2025Aberdeen Group plc72,800$925K0.0%N/A0.554%
8/15/2025Perceptive Advisors LLC139,667$697K0.1%-73.1%1.062%
8/15/2025Boothbay Fund Management LLC11,321$56K0.0%N/A0.086%
8/15/2025BVF Inc. IL1,028,049$5.13M0.2%-0.8%7.818%
8/15/2025Bank of America Corp DE406,571$2.03M0.0%+7,066.8%3.092%
8/14/2025Nantahala Capital Management LLC995,000$4.97M0.2%+10.6%7.565%
8/14/2025Velan Capital Investment Management LP154,972$773K0.8%+38.4%1.178%
8/13/2025Affinity Asset Advisors LLC607,872$3.03M0.4%-7.5%4.623%
8/13/2025Quadrature Capital Ltd10,976$55K0.0%N/A0.083%
8/8/2025Geode Capital Management LLC110,460$552K0.0%+2.5%1.020%
8/6/2025RWA Wealth Partners LLC261,016$1.30M0.0%-16.5%2.410%
Trump's New Dollar (Ad)

Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel

Watch the free briefing and see the three steps to prepare today
5/16/2025Allostery Investments LP107,141$858K1.2%+46.1%0.989%
5/16/2025ADAR1 Capital Management LLC10,000$80K0.0%N/A0.092%
5/15/2025Nantahala Capital Management LLC900,000$7.21M0.3%N/A8.312%
5/14/2025Affinity Asset Advisors LLC657,154$5.26M0.5%+19.3%6.069%
5/14/2025RWA Wealth Partners LLC312,779$2.51M0.0%N/A2.889%
2/17/2025Velan Capital Investment Management LP109,972$817K0.7%N/A1.058%
2/17/2025Deep Track Capital LP867,000$6.44M0.2%-10.3%8.345%
2/17/2025BVF Inc. IL1,036,679$7.70M0.3%+7.2%9.978%
2/17/2025Allostery Investments LP73,314$545K0.6%N/A0.706%
2/14/2025Northern Trust Corp22,673$168K0.0%N/A0.218%


AVTX Institutional Ownership - Frequently Asked Questions

During the previous two years, 72 institutional investors and hedge funds held shares of Avalo Therapeutics. The most heavily invested institutionals were Affinity Asset Advisors LLC ($20.02M), Caligan Partners LP ($16.01M), Nantahala Capital Management LLC ($15.70M), Millennium Management LLC ($11.99M), Adage Capital Partners GP L.L.C. ($9.99M), Bank of America Corp DE ($9.60M), and Ikarian Capital LLC ($9.22M).Learn more on Avalo Therapeutics' institutional investors.

87.06% of Avalo Therapeutics' stock is owned by institutional investors. Learn more on AVTX's institutional investor holdings.

Of the 68 institutional investors that purchased Avalo Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Nantahala Capital Management LLC ($1.24M), Affinity Asset Advisors LLC ($981.78K), RA Capital Management L.P. ($967K), Ikarian Capital LLC ($915.63K), Caligan Partners LP ($881.53K), Balyasny Asset Management L.P. ($817.44K), and Millennium Management LLC ($659.98K).

Institutional investors have bought a total of 10,989,185 shares in the last 24 months. This purchase volume represents approximately $162.82M in transactions.

Of the 17 institutional investors that sold Avalo Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Orbimed Advisors LLC ($874.14K), Deep Track Capital LP ($422.50K), Perceptive Advisors LLC ($380.33K), Balyasny Asset Management L.P. ($378.12K), RA Capital Management L.P. ($270.01K), RWA Wealth Partners LLC ($226.26K), and Renaissance Technologies LLC ($80.40K).

Institutional investors have sold a total of 2,853,760 shares in the last 24 months. This volume of shares sold represents approximately $37.70M in transactions.



This page (NASDAQ:AVTX) was last updated on 7/7/2026 by MarketBeat.com Staff.
From Our Partners